Ping An Biomedical Co

Ping An Biomedical Co Equity

The The Equity of Ping An Biomedical Co (PASW) as of Nov 20, 2026 is -7.19 M CNY. In the previous year, The Equity was -5.86 M CNY — a change of 22.67% (lower).

Equity

-7.19 MCNY

YoY

22.67%

Last updated:

In 2024, Ping An Biomedical Co's equity was -7.19 M CNY, a 22.67% increase from the -5.86 M CNY equity in the previous year.

The Ping An Biomedical Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2022
4.60 M CNY
Jan 1, 2023
-5.86 M CNY
Jan 1, 2024
-7.19 M CNY
The Ping An Biomedical Co Equity history
YEAREquityYoY
-7.19 MCNY+22.67%
-5.86 MCNY-227.39%
4.60 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ping An Biomedical Co Stock analysis

What does Ping An Biomedical Co do? Majestic Ideal Holdings Ltd. generates revenue by providing supply chain management services within the apparel industry. The firm delivers one-stop solutions to customers for a broad range of yarn products, textiles, and finished garments. These services cover functions within the supply chain, including market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The company employs 7 full-time employees to support these operations. The business is organized into two distinct segments. The Sales of Yarns segment is mainly engaged in the provision of yarn products, textiles, and other products. The Sales of Finished Garments segment is mainly engaged in the provision of finished garments. Through these segments, the firm provides end-to-end supply chain solutions to its clients. Ping An Biomedical Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Ping An Biomedical Co's Equity

Ping An Biomedical Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Ping An Biomedical Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Ping An Biomedical Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Ping An Biomedical Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Ping An Biomedical Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Ping An Biomedical Co stock

The Equity of Ping An Biomedical Co is -7.19 M CNY in 2024.

The Equity of Ping An Biomedical Co changed from -5.86 M CNY to -7.19 M CNY, representing a 22.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Ping An Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Ping An Biomedical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Ping An Biomedical Co

All Key Metrics — Ping An Biomedical Co